Hashimoto thyroiditis. Disorders of other endocrine glands
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: All patients under the age of 18 with diagnosis of Hashimoto thyroiditis based on laboratory findings and ultrasonography.
Exclusion criteria
Exclusion criteria: Exit criteria: Patients with thyroid disease, with or without goiter, with normal levels of antibodies, are excluded.Patients with Hashimoto thyroiditis who were already treated.Patients with thyroid disease with or without goiter have normal levels of autoantibodies.Patients with certain chromosomal syndromes, including Down or Turner.Patients with liver and kidney disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome : The therapeutic effects of vitamin D on the level of thyroid autoantibodies in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: The therapeutic effects of vitamin D on reducing thyroid gland in Hashimoto thyroiditis. Timepoint: Time zero and six months later. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Babol University of Medical Sciences